Salute e Benessere
SciBase: A new important customer in the US, Palm Beach Dermatology Group, has placed an initial order for 6 Nevisense.
, the deadliest form of skin cancer, remains a serious and growing public health concern in the United States . According to the American Cancer Society, an estimated will be diagnosed in the U.S. in 2025. Tragically, approximately from melanoma this year. However, early detection is key - when found at an early stage, melanoma has .
said , dermatologist and CEO of Palm Beach Dermatology Group.
," said Pia Renaudin , CEO of SciBase.
Pia Renaudin , CEO, tel. +46732069802, e-mail: pia.renaudin@scibase.com
DNB Carnegie Investment Bank AB (publ) Phone: +46 (0)73 856 42 65 E-mail: certifiedadviser@carnegie.se
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/scibase/r/a-new-important-customer-in-the-us--palm-beach-dermatology-group--has-placed-an-initial-order-for-6-,c4204156
The following files are available for download:
View original content:https://www.prnewswire.co.uk/news-releases/scibase-a-new-important-customer-in-the-us-palm-beach-dermatology-group-has-placed-an-initial-order-for-6-nevisense-302498767.html